Conemans L, Demir E, Bischoff M, Franssen F, Simons S
Respirol Case Rep. 2025; 13(3):e70117.
PMID: 40078572
PMC: 11903096.
DOI: 10.1002/rcr2.70117.
Meng J, Xiao H, Xu F, She X, Liu C, Canonica G
Immunol Res. 2025; 73(1):60.
PMID: 40069459
PMC: 11897119.
DOI: 10.1007/s12026-025-09606-9.
Boyce J, Eisenbarth S
J Clin Invest. 2025; 134(12).
PMID: 40047886
PMC: 11178525.
DOI: 10.1172/JCI182410.
Ten Have L, Meulmeester F, de Jong K, Ten Brinke A
Eur Respir Rev. 2025; 34(175).
PMID: 40044187
PMC: 11880904.
DOI: 10.1183/16000617.0122-2024.
Olsthoorn S, van Krimpen A, Hendriks R, Stadhouders R
Immunol Rev. 2025; 330(1):e70010.
PMID: 40016948
PMC: 11868696.
DOI: 10.1111/imr.70010.
Narrative Review of Genetic and Immunological Mechanisms Involved in the Pathogenesis of Kimura's Disease: New Therapeutic Targets.
Loperfido A, Cavaliere C, Fionda B, Bellocchi G, Masieri S, Caminati M
Genes (Basel). 2025; 16(2).
PMID: 40004521
PMC: 11855017.
DOI: 10.3390/genes16020194.
Location, Location, Location: Spatial Immune-Stroma Crosstalk Drives Pathogenesis in Asthma.
Joulia R, Lloyd C
Immunol Rev. 2025; 330(1):e70013.
PMID: 39991870
PMC: 11848993.
DOI: 10.1111/imr.70013.
T1-T2 Interplay in the Complex Immune Landscape of Severe Asthma.
Gauthier M, Kale S, Ray A
Immunol Rev. 2025; 330(1):e70011.
PMID: 39991821
PMC: 11849004.
DOI: 10.1111/imr.70011.
Microbial influencers: the airway microbiome's role in asthma.
Kim Y, Bunyavanich S
J Clin Invest. 2025; 135(4).
PMID: 39959969
PMC: 11827842.
DOI: 10.1172/JCI184316.
Clinical Characteristics of 31 Patients with Chest Pain Variant Asthma.
Mao W, Gao Y, Sun W, Li J, Wang J, Wang Z
J Asthma Allergy. 2025; 18:173-182.
PMID: 39958457
PMC: 11827699.
DOI: 10.2147/JAA.S494385.
Safety of dupilumab in Chinese pediatric patients aged 6 months and older: a prospective real-world study.
Chen Y, Ni J, Li M, Hong Y, Zhu K, Hong R
Front Pediatr. 2025; 12:1524962.
PMID: 39895989
PMC: 11782127.
DOI: 10.3389/fped.2024.1524962.
Pharmacokinetics of Depemokimab Delivered by Safety Syringe Device or Autoinjector in Healthy Adults: A Phase 1, Single-Dose Study.
Schalkwijk S, Zecchin C, Sen A, Choi S, Wang K, Min J
Clin Pharmacol Drug Dev. 2025; 14(3):190-199.
PMID: 39876532
PMC: 11905874.
DOI: 10.1002/cpdd.1506.
Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution.
De Volder J, Bontinck A, Haelterman V, Boon L, Joos G, Brusselle G
Respir Res. 2025; 26(1):43.
PMID: 39875874
PMC: 11773929.
DOI: 10.1186/s12931-024-03082-9.
Efficacy Assessment of Biological Treatments in Severe Asthma.
Laorden D, Dominguez-Ortega J, Romero D, Villamanan E, Mariscal-Aguilar P, Granda P
J Clin Med. 2025; 14(2).
PMID: 39860330
PMC: 11766327.
DOI: 10.3390/jcm14020321.
Elevating the Importance of Asthma Care in the United States.
Steven G, Skolnik N, Devano M, Wright W, George M
Fed Pract. 2025; 41(Suppl 6):S13-S22.
PMID: 39839065
PMC: 11745465.
DOI: 10.12788/fp.0531.
variant may affect the response to type 2 biologics in patients with severe asthma.
Nishi K, Matsumoto H, Sunadome H, Nagasaki T, Oguma T, Tashima N
ERJ Open Res. 2025; 11(1.
PMID: 39811553
PMC: 11726575.
DOI: 10.1183/23120541.00448-2024.
Biologics in severe asthma: a state-of-the-art review.
Gyawali B, Georas S, Khurana S
Eur Respir Rev. 2025; 34(175).
PMID: 39778920
PMC: 11707604.
DOI: 10.1183/16000617.0088-2024.
Association Between Oxidative Potential of Particulate Matter Collected by Personal Samplers and Systemic Inflammation Among Asthmatic and Non-Asthmatic Adults.
Santibanez M, Ruiz-Cubillan J, Exposito A, Aguero J, Garcia-Rivero J, Abascal B
Antioxidants (Basel). 2025; 13(12.
PMID: 39765793
PMC: 11673029.
DOI: 10.3390/antiox13121464.
Transcriptomic Profiles in Nasal Epithelium and Asthma Endotypes in Youth.
Yue M, Gaietto K, Han Y, Rosser F, Xu Z, Qoyawayma C
JAMA. 2025; 333(4):307-318.
PMID: 39745770
PMC: 11775736.
DOI: 10.1001/jama.2024.22684.
Anti-IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis.
Lamothe P, Pruett C, Smirnova N, Shepherd A, Runnstrom M, Park J
J Allergy Clin Immunol Glob. 2024; 4(1):100369.
PMID: 39736892
PMC: 11683235.
DOI: 10.1016/j.jacig.2024.100369.
